Find verified Pde4-IN-14 API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Pde4-IN-14 for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Pde4-IN-14 API.
Alternate Names: orb1944210, SCHEMBL21486718, CS-0887718
CAS No: 2231329-25-0
PubChem CID: 142395866
Mol Formula: C19H20F2N4O3S
Mol Weight: 422.5 g/mol
IUPAC Name: 1-[[2-(3,6-diazabicyclo[3.1.1]heptan-3-yl)-7-(1,3-thiazol-2-yl)-1,3-benzoxazol-4-yl]oxy]-1,1-difluoro-2-methylpropan-2-ol
API Description: ME3183 (also known as Morcamilast or PDE4‑IN‑14) is an oral, highly selective phosphodiesterase‑4 (PDE4) inhibitor developed by Meiji Seika Pharma, currently investigated for moderate-to-severe plaque psoriasis, with potential applicability in inflammatory dermatological conditions like atopic dermatitis
